Recent studies suggest that the injured adult spinal cord responds to brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3) with enhanced neuron survival and axon regeneration. Potential neurotrophin sources and cellular localization in spinal cord are largely undefined. We examined glial BDNF localization in normal cord and its temporospatial distribution after injury in vivo. We used dual immunolabeling for BDNF and glial fibrillary acidic protein (GFAP) in astrocytes, adenomatous polyposis coli tumor suppressor protein (APC) for oligodendrocytes or type III CDH receptor (OX42) for microglia/macrophages. In normal cord, small subsets of astrocytes and microglia/macrophages and most oligodendrocytes exhibited BDNF-immunoreactivity. Following injury, the number of BDNF-immunopositive astrocytes and microglia/macrophages increased dramatically at the injury site over time. Most oligodendrocytes contained BDNF 1 day and 1 week following injury, but APC-positive cells were largely absent at the injury site 6 weeks postinjury. Glial BDNF-immunolabeling was also examined 10 and 20 mm from the wound. Ten millimeters from the lesion, astrocyte and microglia/macrophage BDNF-immunolabeling resembled that at the injury at all times examined. Twenty millimeters from injury, BDNF localization in all three glial subtypes resembled controls, regardless of time postlesion. Our findings suggest that in normal adult cord, astrocytes, oligodendrocytes, and microglia/macrophages play roles in local trophin availability and in trophin-mediated injury and healing responses directly within and surrounding the wound site.
INTRODUCTION
Functional deficits that follow spinal cord or brain lesions are largely due to failure of damaged axons and their parent neuronal perikarya to exhibit strong regenerative responses. However, recent investigations indicate that treatment of injured CNS tissue with brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT3) may foster postinjury functional recovery by enhancing neuron survival and axon regeneration. This raises a number of questions, since these trophins are present in normal brain and spinal cord. Consequently, temporospatial localization of trophins in the normal and injured central nervous system (CNS) has been the focus of many recent investigations.
In the normal adult spinal cord and brain, neuronal and nonneuronal cells produce neurotrophins and/or exhibit receptor-mediated responses to neurotrophins, including brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and neurotrophin-3 (NT3) (Schnell et al., 1994; Nakahara et al., 1996; Koliatsos et al., 1993; Cho et al., 1998) ; the trophins may potentially act in an autocrine or paracrine fashion. We and others have shown that in brain, oligodendrocytes and microglia/macrophages express NGF, BDNF, and NT3 in vitro and in
